Neurology and Neurosurgery - Global Neurology Academy

Episodes 273-288 of 351

Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Resources
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
Primary Care Today
The Biophysics of Minimizing Brain Damage After Hemorrhagic Stroke
- Brian P. McDonough, MD, FAAFP
- Annalisa Scimemi
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
- Jiwon Oh, MD, PhD
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
Primary Care Today
Head's Up! Why Wearing Bike Helmets Can't Be Overlooked
- Brian P. McDonough, MD, FAAFP
- Howard Spiva
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Resources
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Reducing the Burden of MS Treatment
Reducing the Burden of MS Treatment
Resources
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Resources
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Multiple Sclerosis Physician Resources
Multiple Sclerosis Physician Resources
Resources
Multiple Sclerosis Physician Resources
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Interviews
Immunologic Effects on Metabolic Syndrome and MS
Optimizing MS Treatment Options
Optimizing MS Treatment Options
Interviews
Optimizing MS Treatment Options
Establishing Partnerships to Optimize Patient Outcomes
Establishing Partnerships to Optimize Patient Outcomes
Interviews
Establishing Partnerships to Optimize Patient Outcomes
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Global Neurology Academy
Personalized Approach to Managing MS Patients - Dr. Andrew Chan
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Interviews
Highlights from the MAGNIMS Consensus Guidelines
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
Medical Breakthroughs from Penn Medicine
Neck and Back Pain: When Should You Refer Your Patients to a Neurosurgeon?
- Matt Birnholz, MD
- Patrick J. Connolly, MD
Can Mentally Stimulating Activities Reduce the Risk of Mild Cognitive Impairment in Seniors?
Can Mentally Stimulating Activities Reduce the Risk of Mild Cognitive Impairment in Seniors?
The JAMA Report™
Can Mentally Stimulating Activities Reduce the Risk of Mild Cognitive Impairment in Seniors?
FDA Approves Focused Ultrasound Therapy for Essential Tremor
FDA Approves Focused Ultrasound Therapy for Essential Tremor
What Your Patients Are Talking About
FDA Approves Focused Ultrasound Therapy for Essential Tremor
- Brian P. McDonough, MD, FAAFP

18/10